Prognostic Utility of the Glasgow Prognostic Score for the Long-Term Outcomes After Liver Resection for Intrahepatic Cholangiocarcinoma: A Multi-institutional Study

[1]  N. Harada,et al.  Association of inflammatory biomarkers with long-term outcomes after curative surgery for mass-forming intrahepatic cholangiocarcinoma , 2019, Surgery Today.

[2]  J. Weitz,et al.  The MEGNA Score and Preoperative Anemia are Major Prognostic Factors After Resection in the German Intrahepatic Cholangiocarcinoma Cohort , 2019, Annals of Surgical Oncology.

[3]  P. Rodrigues,et al.  Metabolic rearrangements in primary liver cancers: cause and consequences , 2019, Nature Reviews Gastroenterology & Hepatology.

[4]  J. Raftery,et al.  Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. , 2019, The Lancet. Oncology.

[5]  D. McMillan,et al.  The relationship between computed tomography‐derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer , 2018, Journal of cachexia, sarcopenia and muscle.

[6]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[7]  A. Lamarca,et al.  Biliary Tract Cancer: State of the Art and potential role of DNA Damage Repair. , 2018, Cancer treatment reviews.

[8]  Y. Shimada,et al.  A Novel Physiobiological Parameter-Based Grading System for Resectable Pancreatic Cancer , 2018, Annals of Surgical Oncology.

[9]  H. El‐Serag,et al.  Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma , 2017, Cancer control : journal of the Moffitt Cancer Center.

[10]  J. Izbicki,et al.  Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma , 2017, British Journal of Cancer.

[11]  Qunxiong Pan,et al.  Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma. , 2017, Molecular and clinical oncology.

[12]  N. Pavlakis,et al.  The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer , 2016, Annals of surgery.

[13]  Sheng-ping Li,et al.  Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma , 2016, Oncotarget.

[14]  T. Pawlik,et al.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. , 2014, Journal of hepatology.

[15]  P. Rogers.  Nutritional status as a prognostic indicator for pediatric malignancies. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  L. Antonioli,et al.  Immunity, inflammation and cancer: a leading role for adenosine , 2013, Nature Reviews Cancer.

[17]  K. Chayama,et al.  Elevated expression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 in primary sclerosing cholangitis: ιmplications for cholangiocarcinogenesis. , 2013, International journal of oncology.

[18]  T. Yamanaka,et al.  Preoperative Neutrophil-to-Lymphocyte Ratio Is a Predictor of Survival After Hepatectomy for Hepatocellular Carcinoma: A Retrospective Analysis , 2013, Annals of surgery.

[19]  Kui Wang,et al.  Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  A. Neugut,et al.  Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer , 2011, Annals of Surgical Oncology.

[21]  P. Allavena,et al.  Cancer-related inflammation , 2008, Nature.

[22]  D. McMillan,et al.  An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer , 2008, Proceedings of the Nutrition Society.

[23]  N. LaRusso,et al.  The Pathophysiology of Biliary Epithelia , 2004 .

[24]  N. LaRusso,et al.  The pathobiology of biliary epithelia , 2002, Hepatology.

[25]  M. Makuuchi,et al.  A new staging system for mass‐forming intrahepatic cholangiocarcinoma , 2001, Cancer.

[26]  R. Smith.  Cause and Consequences , 2011 .